Data / Form D filings / Abzena plc
Abzena plc: Form D filings
Abzena plc, a biotechnology company in Cambridge, United Kingdom, filed 2 Form D notices with the SEC in 2015. The latest, on December 23, 2015, reports $3.6 million sold of a $3.6 million offering to 2 investors.
Find out what Abzena plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- BABRAHAM RESEARCH CAMPUS, BABRAHAM, Cambridge, United Kingdom, CB22
- Phone
- 44(0)1223903498
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1653673
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2015 | New notice | $3,603,185 | $3,603,185 | $0 | 2 | Dec 11, 2015 | sec.gov |
| Sep 25, 2015 | New notice | $700,000 | $700,000 | $0 | 7 | Sep 11, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jim John Edward Mills | Executive Officer | |
| Kenneth John Edward Cunningham | Director | |
| Campbell John Edward Bunce | Executive Officer | |
| Nareshkumar John Edward Jain | Executive Officer | |
| Gary John Edward Pierce | Executive Officer | |
| Anker John Edward Lundemose | Director | |
| Julian John Edward Smith | Executive Officer, Director | |
| William John Edward Burt | Executive Officer, Director | |
| Leigh John Edward Pierce | Executive Officer | |
| Nigel John Edward Pitchford | Director | |
| Sally John Edward Waterman | Executive Officer | |
| Matthew John Edward Baker | Executive Officer | |
| Peter John Edward Grant | Director | |
| Anthony John Edward Brampton | Director |
Every Form D from the week of Dec 21, 2015 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Abzena plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.